179 related articles for article (PubMed ID: 2199681)
1. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.
Love RR; Newcomb PA; Wiebe DA; Surawicz TS; Jordan VC; Carbone PP; DeMets DL
J Natl Cancer Inst; 1990 Aug; 82(16):1327-32. PubMed ID: 2199681
[TBL] [Abstract][Full Text] [Related]
2. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.
Love RR; Wiebe DA; Newcomb PA; Cameron L; Leventhal H; Jordan VC; Feyzi J; DeMets DL
Ann Intern Med; 1991 Dec; 115(11):860-4. PubMed ID: 1952472
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
Ilanchezhian S; Thangaraju M; Sachdanandam P
Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
[TBL] [Abstract][Full Text] [Related]
4. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
[TBL] [Abstract][Full Text] [Related]
5. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
Wasan KM; Ramaswamy M; Haley J; Dunn BP
J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
[TBL] [Abstract][Full Text] [Related]
6. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.
Joensuu H; Holli K; Oksanen H; Valavaara R
Breast Cancer Res Treat; 2000 Oct; 63(3):225-34. PubMed ID: 11110056
[TBL] [Abstract][Full Text] [Related]
7. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
[TBL] [Abstract][Full Text] [Related]
8. Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancer.
Thangaraju M; Kumar K; Gandhirajan R; Sachdanandam P
Cancer; 1994 Feb; 73(3):659-63. PubMed ID: 8299087
[TBL] [Abstract][Full Text] [Related]
9. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
[TBL] [Abstract][Full Text] [Related]
10. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
11. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen, serum lipoproteins and cardiovascular risk.
Bruning PF; Bonfrer JM; Hart AA; de Jong-Bakker M; Linders D; van Loon J; Nooyen WJ
Br J Cancer; 1988 Oct; 58(4):497-9. PubMed ID: 3207604
[TBL] [Abstract][Full Text] [Related]
13. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.
Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
Clin Chim Acta; 1993 Dec; 223(1-2):43-52. PubMed ID: 8143369
[TBL] [Abstract][Full Text] [Related]
14. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
[TBL] [Abstract][Full Text] [Related]
15. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
Esteva FJ; Hortobagyi GN
Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
[TBL] [Abstract][Full Text] [Related]
16. Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.
Morales M; Santana N; Soria A; Mosquera A; Ordovás J; Nóvoa J; Betancor P; Valerón PF; Díaz-Chico B; Chirino R
Breast Cancer Res Treat; 1996; 40(3):265-70. PubMed ID: 8883969
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.
Love RR; Wiebe DA; Feyzi JM; Newcomb PA; Chappell RJ
J Natl Cancer Inst; 1994 Oct; 86(20):1534-9. PubMed ID: 7932809
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum lipid and lipoprotein levels in postmenopausal patients with node-positive breast cancer treated with tamoxifen.
Vrbanec D; Reiner Z; Belev B; Plestina S
Tumori; 1998; 84(6):687-90. PubMed ID: 10080678
[TBL] [Abstract][Full Text] [Related]
19. Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme.
Powles TJ; Tillyer CR; Jones AL; Ashley SE; Treleaven J; Davey JB; McKinna JA
Eur J Cancer; 1990; 26(6):680-4. PubMed ID: 2144154
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
